Interim report for the six months ended June 30, 2008

 | Source: Affitech A/S Affitech A/S 

Summary: For the first six months of 2008 the Pharmexa Group generated revenues
and other operating income of DKK 12,659 thousand and a net loss of DKK 75,914
thousand. Research and development costs totalled DKK 76,558 thousand. The
Pharmexa Group retains its financial forecast for the full year.

Pièces jointes

pharmexa press release 2008-20-uk.pdf
GlobeNewswire